TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue152.381152.381152.381152.381
Cost of Revenue----
Gross Profit152.381152.381152.381152.381
Operating Expenses
Research Development102,532.8569,232.17447,707.22340,086.347
Selling General and Administrative16,331.2829,889.33515,625.17415,787.126
Non Recurring----
Others----
Total Operating Expenses118,864.13279,121.50963,332.39755,873.473
Operating Income or Loss-118,711.751-78,969.128-63,180.016-55,721.092
Income from Continuing Operations
Total Other Income/Expenses Net235.739716.234231.37-60.185
Earnings Before Interest and Taxes-118,711.751-78,969.128-63,180.016-55,721.092
Interest Expense----
Income Before Tax-118,476.012-78,252.894-62,948.646-55,781.277
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-118,476.012-78,252.894-62,948.646-55,781.277
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-118,476.012-78,252.894-62,948.646-55,781.277
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-118,476.012-78,252.894-62,948.646-55,781.277